Unspecified type of carcinoma in situ of the right breast refers to a localized, non-invasive breast cancer that has not yet spread beyond the ducts or lobules. This condition is clinically significant as it can progress to invasive cancer if not monitored and treated appropriately. The ICD-10 Code D05.91 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage patient care.
ICD-10 Code D05.91 represents an unspecified type of carcinoma in situ of the right breast, indicating a non-invasive breast cancer diagnosis. This code is used when the specific type of carcinoma in situ is not identified. It is essential for clinical documentation and billing, particularly when patients present with symptoms or findings that warrant further investigation or treatment.
Unspecified type of carcinoma in situ of the right breast is characterized by abnormal cell growth within the breast ducts or lobules, which has not invaded surrounding tissues. This condition requires medical attention due to its potential to develop into invasive breast cancer. Early detection and management are crucial for favorable outcomes.
In clinical workflows, ICD-10 Code D05.91 is utilized in SOAP notes to document the patient's symptoms, assessment, and treatment plan. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management and facilitating appropriate billing practices.
ICD-10 Code D05.91 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of carcinoma in situ. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of unspecified type of carcinoma in situ of the right breast typically involves surgical intervention and may include adjuvant therapies. Prompt treatment is essential to prevent progression to invasive cancer.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D05.91 is crucial for accurate billing in hospital, ER, or oncology settings, ensuring proper reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 19301 | Mastectomy, total or partial. |
| 19281 | Biopsy of breast, needle core. |
| 77067 | Mammography, diagnostic. |
| 99406 | Smoking and tobacco use cessation counseling visit. |
Common Questions About Using ICD-10 Code D05.91 for Unspecified type of carcinoma in situ of right breast
What are the common symptoms of carcinoma in situ?
Common symptoms include the presence of a lump in the breast, changes in breast shape or size, and abnormal mammogram findings. However, many cases may be asymptomatic.
How is carcinoma in situ treated?
Treatment typically involves surgical options such as lumpectomy or mastectomy, often followed by radiation therapy. The specific approach depends on individual patient factors.
Is carcinoma in situ considered cancer?
Yes, carcinoma in situ is classified as a non-invasive cancer. While it does not spread beyond the ducts or lobules, it has the potential to develop into invasive cancer if left untreated.
How often should follow-up care occur after diagnosis?
Follow-up care typically includes regular clinical evaluations and imaging studies every 6 to 12 months, depending on the treatment plan and individual risk factors.
Clinical Notes
SOAP notes
DAP notes
AI medical notes